Fabhalta (Iptacopan) is used to treat Paroxysmal Nocturnal Hemoglobinuria (PNH) and Immunoglobulin A Nephropathy (IgAN). Fabhalta is a Complement Inhibitor, which works by slowing down an overactive immune system. Fabhalta is only available as a brand name drug.
This Co-Pay Plus offer through Novartis Patient Support™ may help you pay for out-of-pocket costs related to your prescription, including refills. If you have private insurance, you may be eligible.
Call 833-99FABHA (833-933-2242) Monday-Friday, 8:00 AM-8:00 PM ET, excluding holidays. Your dedicated Novartis Patient Support team can help sign you up.
*Co-Pay Plus: Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state programs. Patients with commercial insurance coverage for FABHALTA may receive up to $20,000 in annual co-pay benefits for the cost of FABHALTA and up to $1,000 for qualifying vaccination costs. Patients with commercial insurance and a prior authorization requirement may receive up to 12 months of free product while coverage is pursued. A prior authorization and/or appeal of coverage denial must be submitted within 90 days to remain in the program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions at www.fabhalta.com for details.